Gene · 10253
Papers1,626
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,626
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma. | Cancer Cell Int | 2023 | 38012755 | PubTator, text mining | PubMed |
| Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study. | Int J Mol Sci | 2023 | 37958966 | PubTator, text mining | PubMed |
| Diminished ovarian reserve causes adverse ART outcomes attributed to effects on oxygen metabolism function in cumulus cells. | BMC Genomics | 2023 | 37907878 | PubTator, text mining | PubMed |
| Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review. | Front Oncol | 2023 | 37869088 | PubTator, text mining | PubMed |
| Beyond apples and pears: sex-specific genetics of body fat percentage. | Front Endocrinol (Lausanne) | 2023 | 37867527 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. | Cell Death Discov | 2023 | 37845209 | PubTator, text mining | PubMed |
| Thrombotic Alterations under Perinatal Hypoxic Conditions: HIF and Other Hypoxic Markers. | Int J Mol Sci | 2023 | 37833987 | PubTator, text mining | PubMed |
| MicroRNAs in atrial fibrillation target genes in structural remodelling. | Cell Tissue Res | 2023 | 37833432 | PubTator, text mining | PubMed |
| The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37767397 | PubTator, text mining | PubMed |
| Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells. | Genes (Basel) | 2023 | 37761870 | PubTator, text mining | PubMed |
| Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart. | Biomolecules | 2023 | 37759809 | PubTator, text mining | PubMed |
| XBP1 promotes NRASG12D pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS. | J Cell Mol Med | 2023 | 37753803 | PubTator, text mining | PubMed |
| Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning. | Front Genet | 2023 | 37732314 | PubTator, text mining | PubMed |
| miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. | Technol Cancer Res Treat | 2023 | 37728167 | PubTator, text mining | PubMed |
| microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration. | Front Bioeng Biotechnol | 2023 | 37720323 | PubTator, text mining | PubMed |
| Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia. | Clin Epigenetics | 2023 | 37705055 | PubTator, text mining | PubMed |
| Setting sail: Maneuvering SHP2 activity and its effects in cancer. | Adv Cancer Res | 2023 | 37704288 | PubTator, text mining | PubMed |
| The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer. | Am J Clin Oncol | 2023 | 37700432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10253/papers?page=4